Condition

Lennox-Gastaut Syndrome

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyNCT05626634 · 2022-11-08

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesNCT03650452 · 2018-08-08

Turmeric as Treatment in EpilepsyNCT03254680 · 2018-03-01

Common interventions

LP352, bexicaserinDRUG1 PlaceboDRUG1 TAK-935DRUG1 TurmericDIETARY_SUPPLEMENT1

Leading sponsors

Longboard Pharmaceuticals1 NYU Langone Health1 Takeda1

Trial status mix

COMPLETED2

WITHDRAWN1

Phase mix

PHASE22

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.